List of Tables
Table 1. Global Optogenetic Gene Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Optogenetic Gene Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Optogenetic Gene Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Optogenetic Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Optogenetic Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Optogenetic Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Optogenetic Gene Therapy Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Optogenetic Gene Therapy by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Optogenetic Gene Therapy as of 2024)
Table 11. Global Optogenetic Gene Therapy Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Optogenetic Gene Therapy Companies Headquarters
Table 13. Global Optogenetic Gene Therapy Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Optogenetic Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Optogenetic Gene Therapy Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Optogenetic Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Optogenetic Gene Therapy Revenue by Application (2026-2031) & (US$ Million)
Table 21. Optogenetic Gene Therapy High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Optogenetic Gene Therapy Growth Accelerators and Market Barriers
Table 25. North America Optogenetic Gene Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Optogenetic Gene Therapy Growth Accelerators and Market Barriers
Table 27. Europe Optogenetic Gene Therapy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Optogenetic Gene Therapy Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Optogenetic Gene Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Optogenetic Gene Therapy Investment Opportunities and Key Challenges
Table 31. Central and South America Optogenetic Gene Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Optogenetic Gene Therapy Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Optogenetic Gene Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Bionic Sight Corporation Information
Table 35. Bionic Sight Description and Major Businesses
Table 36. Bionic Sight Product Features and Attributes
Table 37. Bionic Sight Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Bionic Sight Revenue Proportion by Product in 2024
Table 39. Bionic Sight Revenue Proportion by Application in 2024
Table 40. Bionic Sight Revenue Proportion by Geographic Area in 2024
Table 41. Bionic Sight Optogenetic Gene Therapy SWOT Analysis
Table 42. Bionic Sight Recent Developments
Table 43. Nanoscope Therapeutics Corporation Information
Table 44. Nanoscope Therapeutics Description and Major Businesses
Table 45. Nanoscope Therapeutics Product Features and Attributes
Table 46. Nanoscope Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Nanoscope Therapeutics Revenue Proportion by Product in 2024
Table 48. Nanoscope Therapeutics Revenue Proportion by Application in 2024
Table 49. Nanoscope Therapeutics Revenue Proportion by Geographic Area in 2024
Table 50. Nanoscope Therapeutics Optogenetic Gene Therapy SWOT Analysis
Table 51. Nanoscope Therapeutics Recent Developments
Table 52. GenSight Biologics Corporation Information
Table 53. GenSight Biologics Description and Major Businesses
Table 54. GenSight Biologics Product Features and Attributes
Table 55. GenSight Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. GenSight Biologics Revenue Proportion by Product in 2024
Table 57. GenSight Biologics Revenue Proportion by Application in 2024
Table 58. GenSight Biologics Revenue Proportion by Geographic Area in 2024
Table 59. GenSight Biologics Optogenetic Gene Therapy SWOT Analysis
Table 60. GenSight Biologics Recent Developments
Table 61. Allergan Corporation Information
Table 62. Allergan Description and Major Businesses
Table 63. Allergan Product Features and Attributes
Table 64. Allergan Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Allergan Revenue Proportion by Product in 2024
Table 66. Allergan Revenue Proportion by Application in 2024
Table 67. Allergan Revenue Proportion by Geographic Area in 2024
Table 68. Allergan Optogenetic Gene Therapy SWOT Analysis
Table 69. Allergan Recent Developments
Table 70. Ray Therapeutics Corporation Information
Table 71. Ray Therapeutics Description and Major Businesses
Table 72. Ray Therapeutics Product Features and Attributes
Table 73. Ray Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Ray Therapeutics Revenue Proportion by Product in 2024
Table 75. Ray Therapeutics Revenue Proportion by Application in 2024
Table 76. Ray Therapeutics Revenue Proportion by Geographic Area in 2024
Table 77. Ray Therapeutics Optogenetic Gene Therapy SWOT Analysis
Table 78. Ray Therapeutics Recent Developments
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Product Features and Attributes
Table 82. Novartis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Novartis Recent Developments
Table 84. GenAns Biotechnology Corporation Information
Table 85. GenAns Biotechnology Description and Major Businesses
Table 86. GenAns Biotechnology Product Features and Attributes
Table 87. GenAns Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GenAns Biotechnology Recent Developments
Table 89. UgeneX Corporation Information
Table 90. UgeneX Description and Major Businesses
Table 91. UgeneX Product Features and Attributes
Table 92. UgeneX Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. UgeneX Recent Developments
Table 94. Raw Materials Key Suppliers
Table 95. Distributors List
Table 96. Market Trends and Market Evolution
Table 97. Market Drivers and Opportunities
Table 98. Market Challenges, Risks, and Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Optogenetic Gene Therapy Product Picture
Figure 2. Global Optogenetic Gene Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Light Sensitive Protein Product Picture
Figure 4. Light Sensitive Protein Transporter Product Picture
Figure 5. Light Stimulation System Product Picture
Figure 6. Global Optogenetic Gene Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Neurological Diseases
Figure 8. Retinal Diseases
Figure 9. Others
Figure 10. Optogenetic Gene Therapy Report Years Considered
Figure 11. Global Optogenetic Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 13. Global Optogenetic Gene Therapy Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Optogenetic Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 15. Global Optogenetic Gene Therapy Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Light Sensitive Protein Revenue Market Share by Player in 2024
Figure 18. Light Sensitive Protein Transporter Revenue Market Share by Player in 2024
Figure 19. Light Stimulation System Revenue Market Share by Player in 2024
Figure 20. Global Optogenetic Gene Therapy Revenue Market Share by Type (2020-2031)
Figure 21. Global Optogenetic Gene Therapy Revenue Market Share by Application (2020-2031)
Figure 22. North America Optogenetic Gene Therapy Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Optogenetic Gene Therapy Revenue (US$ Million) in 2024
Figure 24. North America Optogenetic Gene Therapy Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Optogenetic Gene Therapy Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Optogenetic Gene Therapy Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Optogenetic Gene Therapy Revenue (US$ Million) in 2024
Figure 31. Europe Optogenetic Gene Therapy Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Optogenetic Gene Therapy Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 34. France Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Optogenetic Gene Therapy Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Optogenetic Gene Therapy Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Optogenetic Gene Therapy Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Optogenetic Gene Therapy Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 46. India Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Optogenetic Gene Therapy Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Optogenetic Gene Therapy Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Optogenetic Gene Therapy Revenue (US$ Million) in 2024
Figure 54. Central and South America Optogenetic Gene Therapy Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Optogenetic Gene Therapy Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Optogenetic Gene Therapy Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Optogenetic Gene Therapy Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Optogenetic Gene Therapy Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Optogenetic Gene Therapy Revenue (US$ Million) in 2024
Figure 60. South America Optogenetic Gene Therapy Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Optogenetic Gene Therapy Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Optogenetic Gene Therapy Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Optogenetic Gene Therapy Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Optogenetic Gene Therapy Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Optogenetic Gene Therapy Revenue (2020-2025) & (US$ Million)
Figure 66. Optogenetic Gene Therapy Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
